Bill Information for HB 2107

HB 2107 by Pae and Brooks

Select Session:

Enter Bill #:

Receive Email Updates for this Measure (LENS)

Controlled dangerous substances; authorizing certain scientific research and clinical trials related to psilocybin and psilocyn; requiring registration; providing certain immunities; effective date.

History

Amendments

Bill Summaries

Versions

Votes

Authors/Co Authors

History For HB 2107
Action	Journal Page	Date	Chamber
First Reading	183	02/06/2023	H

Authored by Representative Pae	183	02/06/2023	H

Second Reading referred to Alcohol, Tobacco and Controlled Substances	324	02/07/2023	H

CR; Do Pass, amended by committee substitute Alcohol, Tobacco and Controlled Substances Committee	361	02/15/2023	H

General Order	581	03/09/2023	H

Coauthored by Representative(s) Talley, Hefner, Deck	581	03/09/2023	H

Authored by Senator Brooks (principal Senate author)	581	03/09/2023	H

Amended	582	03/09/2023	H

Title stricken	582	03/09/2023	H

Third Reading, Measure passed: Ayes: 66 Nays: 32	582	03/09/2023	H

Referred for engrossment	582	03/09/2023	H

Engrossed, signed, to Senate	609	03/13/2023	H

First Reading	663	03/13/2023	S

Coauthored by Representative Rosecrants	693	03/14/2023	S

Coauthored by Representative Munson	693	03/14/2023	S

Second Reading referred to Health and Human Services Committee then to Appropriations Committee	865	03/29/2023	S

Floor Amendments (Senate)
None
Floor Amendments (House)
1 Floor Amendment by MARTINEZ (UNTIMELY FILED)	3/9/2023

None
Committee Amendments (Senate)
None
Committee Amendments (House)
Proposed Committee Substitute (full committee) 1	2/14/2023

Sub Committee OR Policy Committee Recommendations (House)
None

Bill Summaries/Fiscal Impact for HB 2107 (House)
Committee Substitute	3/8/2023

Proposed Committee Substitute (full committee) 1	2/23/2023

Introduced	2/14/2023

Bill Summaries/Fiscal Impact for HB 2107 (Senate)
None
OPLAA Actuarial Statements For HB 2107 (House)
None
OPLAA Actuarial Statements For HB 2107 (Senate)
None
Fiscal Impact Statements For HB 2107 (House)
None
Fiscal Impact Statements For HB 2107 (Senate)
None

Versions of HB 2107
Introduced	1/19/2023

House Committee Substitute	2/15/2023

Floor (House)	2/16/2023

Engrossed	3/13/2023

Committee Reports for HB 2107
House Committee Report	2/15/2023

Conference Committee Reports for HB 2107

Votes on HB 2107
HB2107_VOTES.HTM	All House Votes

None

Authors/Co Authors for HB 2107

Munson (H)

Rosecrants (H)

Talley (H)

Deck (H)

Hefner (H)

***To be added when the next official action is taken on the measure.***

***Please be aware that for measures under consideration in the House of Representatives not all author/coauthor information displayed on this page will immediately appear in the legislative history of the bill. When a measure is under consideration in the House, the measure’s legislative history is updated only when the next official action is taken on the measure.***

********* All Submitted Requests *********

Add as principal Senate author Senator Brooks
Add as coauthor Representative Talley
Add as coauthor Representative Hefner
Add as coauthor Representative Deck
Add as coauthor Representative Rosecrants
Add as coauthor Representative Munson

Address: 2300 N Lincoln Blvd., State Capitol Building, Oklahoma City, OK 73105

Bill Information for HB 2107

History For HB 2107

Floor Amendments (Senate)

Floor Amendments (House)

Committee Amendments (Senate)

Committee Amendments (House)

Sub Committee OR Policy Committee Recommendations (House)

Bill Summaries/Fiscal Impact for HB 2107 (House)

Bill Summaries/Fiscal Impact for HB 2107 (Senate)

OPLAA Actuarial Statements For HB 2107 (House)

OPLAA Actuarial Statements For HB 2107 (Senate)

Fiscal Impact Statements For HB 2107 (House)

Fiscal Impact Statements For HB 2107 (Senate)

Versions of HB 2107

Committee Reports for HB 2107

Conference Committee Reports for HB 2107

Votes on HB 2107

Authors/Co Authors for HB 2107